Afya (NASDAQ:AFYA) Insider Santos Welder Ferreira Sells 3,325 Shares

April 21, 2026 by InsiderTrades.com

Key Points

Insider sale: Santos Welder Ferreira sold 3,325 Afya shares on April 17 at $15.90 each, reducing his holding to 35,000 shares—a reported 8.68% decrease in ownership.
Quarterly results: Afya topped EPS estimates ($0.41 vs. $0.36) but missed revenue expectations ($147.08M vs. $174.74M), with a net margin of 20.31% and return on equity of 18.77%.
Dividend and outlook: The company paid an annual dividend of $0.656 per share on April 6 and carries an average analyst rating of "Hold" with a $17.30 average price target.

Afya Limited (NASDAQ:AFYA - Get Free Report) insider Santos Welder Ferreira sold 3,325 shares of the company's stock in a transaction on Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the transaction, the insider owned 35,000 shares of the company's stock, valued at $556,500. This represents a 8.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Afya Stock Performance

NASDAQ:AFYA opened at $15.82 on Tuesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.20 and a current ratio of 2.20. The company has a fifty day moving average of $14.54 and a two-hundred day moving average of $14.68. The stock has a market capitalization of $1.48 billion, a PE ratio of 10.84, a P/E/G ratio of 0.71 and a beta of 0.48. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $19.90.

Afya (NASDAQ:AFYA - Get Free Report) last posted its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.05. The company had revenue of $147.08 million during the quarter, compared to analysts' expectations of $174.74 million. Afya had a net margin of 20.31% and a return on equity of 18.77%. As a group, research analysts forecast that Afya Limited will post 1.67 earnings per share for the current fiscal year.

Afya Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were paid a dividend of $0.656 per share. This represents a yield of 433.0%. The ex-dividend date was Wednesday, March 25th. Afya's payout ratio is 45.21%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Doma Perpetual Capital Management LLC increased its stake in shares of Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company's stock worth $13,910,000 after acquiring an additional 299,419 shares during the last quarter. SPX Gestao de Recursos Ltda acquired a new stake in shares of Afya in the 3rd quarter worth $2,895,000. Swedbank AB increased its stake in shares of Afya by 170.3% in the 4th quarter. Swedbank AB now owns 189,200 shares of the company's stock worth $2,916,000 after acquiring an additional 119,200 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of Afya in the 2nd quarter valued at approximately $731,000. Finally, Qube Research & Technologies Ltd purchased a new stake in shares of Afya in the 3rd quarter valued at approximately $610,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on AFYA. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $22.00 price objective (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Weiss Ratings reiterated a "hold (c)" rating on shares of Afya in a research note on Wednesday, January 21st. Zacks Research upgraded Afya from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, April 7th. Wall Street Zen raised shares of Afya from a "buy" rating to a "strong-buy" rating in a research note on Saturday, March 14th. Finally, Sanford C. Bernstein raised shares of Afya to a "market perform" rating in a research note on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Afya currently has an average rating of "Hold" and an average price target of $17.30.

Get Our Latest Stock Report on Afya

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.